Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 155.11 K164.94 K140.32 K228.09 K219.15 K1.32 M 1.9 M Research & development —————— — Operating income -155.11 K-164.94 K-140.32 K-228.09 K-219.15 K-1.32 M -1.9 M Non-Operating Income, Total 1.84 M1.85 M1.87 M1.75 M1.61 M1.63 M 6.85 M Interest expense, net of interest capitalized 100 K100 K100 K100 K100 K100 K 400 K Non-Operating Income, excl. Interest Expenses 1.84 M1.85 M1.87 M1.75 M1.61 M1.63 M 6.85 M Unusual income/expense —————— — Pretax income 1.69 M1.69 M1.73 M1.52 M1.39 M311.3 K 4.95 M Equity in earnings —————— — Taxes 000000 0 Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 1.69 M1.69 M1.73 M1.52 M1.39 M311.3 K 4.95 M Discontinued operations —————— — Net income 1.69 M1.69 M1.73 M1.52 M1.39 M311.3 K 4.95 M Dilution adjustment 1.83 M1.84 M1.86 M1.74 M1.6 M— — Preferred dividends 1.83 M1.84 M1.86 M1.74 M1.6 M— — Diluted net income available to common stockholders 1.69 M1.69 M1.73 M1.52 M1.39 M311.3 K 4.95 M Basic earnings per share (Basic EPS) 0.070.070.280.240.240.04 0.8 Diluted earnings per share (Diluted EPS) 0.070.070.140.120.240.04 0.54 Average basic shares outstanding 17.25 M17.25 M48.23 M48.23 M48.23 M48.23 M — Diluted shares outstanding 6.87 M6.87 M46.64 M49.03 M48.23 M48.23 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —